Prevalence and Predictors of Post-coital Hypoglycemia in Diabetes Mellitus

Qasem Al Jabr1, Ali A Bu-Khamseen2, Mohammed Alalawi3

  • 1Family Medicine, Geriatric Medicine, Postgraduate Center of Family Medicine in Al-Ahsa, Al-Ahsa, SAU.

Cureus
|October 1, 2025
PubMed

Insights

Post-coital hypoglycemia affects nearly 18% of diabetes patients, particularly insulin users and those with type 1 diabetes mellitus. This highlights the need for healthcare providers to discuss sexual health and hypoglycemia risks during diabetes management.

Area of Science:

  • Endocrinology
  • Diabetes Mellitus Management
  • Sexual Health in Chronic Illness

Background:

  • Post-coital hypoglycemia is an underrecognized complication in diabetes management.
  • Sexual activity can precipitate hypoglycemic events in individuals with diabetes.

Purpose of the Study:

  • To determine the prevalence and associated factors of post-coital hypoglycemia in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) patients.
  • To identify risk factors and common symptoms of post-coital hypoglycemia.

Main Methods:

  • Cross-sectional study involving 821 T1DM and T2DM patients in Al-Ahsa, Saudi Arabia.
  • Telephone interviews using a structured questionnaire to collect data on hypoglycemic events, medication use, and demographics.

Main Results:

  • 17.9% of participants reported experiencing post-coital hypoglycemia.
  • Insulin use (28.3%) and T1DM diagnosis (92.5% of cases) were strongly associated with increased risk.
  • Younger age, higher education, married status, and specific oral medications (metformin, sitagliptin, gliclazide-sulfonylurea) were also linked to higher incidence.

Conclusions:

  • Post-coital hypoglycemia is prevalent among diabetes patients, especially insulin users and T1DM patients.
  • Healthcare providers should integrate sexual health and hypoglycemia risk discussions into routine diabetes care.
  • Targeted interventions and further research are needed to prevent and manage this complication, improving patient quality of life.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
835
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
600